Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Multiple Sclerosis (MS) · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Primary Progressive · Multiple Sclerosis, Chronic Progressive · Multiple Sclerosis Relapse · Multiple Sclerosis Brain Lesion · Multiple Sclerosis Benign
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco, California, United States
Contact: Study coordinator (Angelica Montevirgen, BS) · Angelica.Montevirgen@ucsf.edu · 415-745-1304Contact: Principal Investigator (Ari J Green, MD)
Study leads
Ari J Green, MD, MCR
Principal Investigator
University of California, San Francisco